The role of Helicobacter cinaedi in the development of atherosclerosis
By:
References
- Goodwin C.S., Armstrong J.A., Chilvers T., Peters M., Collins M.D., Sly L., McConnell W., Harper W.E.: Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov., as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively. Int. J. Syst. Bacteriol., 1989; 39: 397-405
- De Witte C., Schulz C., Smet A., Malfertheiner P., Haesebrouck F.: Other Helicobacters and gastric microbiota. Helicobacter, 2016; 21: 62-68
- Taniguchi T., Yamazaki W., Saeki Y., Takajo I., Okayama A., Hayashi T., Misawa N.: The pathogenic potential of Helicobacter cinaedi isolated from non-human sources: Adherence, invasion and translocation ability in polarized intestinal epithelial Caco-2 cells in vitro. J. Vet. Med. Sci., 2016; 78: 627-632
- Nakamura I., Ohkusu K., Nakagami Y., Tachibana M., Matsumoto T.: First case report of bacteremia due to ‘Campylobacter-like organism 3’. Int. J. Infect. Dis., 2016; 42: 51-53
- Uwamino Y., Muranaka K., Hase R., Otsuka Y., Hosokawa N.: Clinical features of community acquired Helicobacter cinaedi bacteremia. Helicobacter, 2016; 21: 24-28
- Epstein S.E.: The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ. Res., 2002; 90: 2-4
- Michelsen K.S., Doherty T.M., Shah P.K., Arditi M.: TLR signaling: An emerging bridge from innate immunity to atherogenesis. J. Immunol., 2004; 173: 5901-5907
- Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Mäkelä P.H., Huttunen J.K., Valtonen V.: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, 1988; 2: 983-986
- Hajjar D.P., Pomerantz K.B., Falcone D.J., Weksler B.B., Grant A.J.: Herpes simplex virus infection in human arterial cells: Implications in arteriosclerosis. J. Clin. Invest., 1987; 80: 1317-1321
- Ameriso S.F., Fridman E.A., Leiguarda R.C., Sevlever G.E.: Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke, 2001; 32: 385-391
- Ziver T., Yuksel P., Ipek G., Yekeler I., Bayramoglu Z., Tireli E, Saribas S., Aslan M., Yalvac S.D., Ozdomanic I., et al.: Aneurysm and Helicobacter pylori relationship: The seropositivity of CagA, VacA and other antigens of Helicobacter pylori in abdominal and ascending aortic aneurysms. New Microbiol., 2010; 33: 233-242
- Khan S., Okamoto T., Enomoto K., Sakashita N., Oyama K., Fujii S., Sawa T., Takeya M., Ogawa H., Yamabe H., Akaike T.: Potential association of Helicobacter cinaedi with atrial arrhythmias and atherosclerosis. Microbiol. Immunol., 2012; 56: 145-154
- Oyama K., Khan S., Okamoto T., Fujii S., Ono K., Matsunaga T., Yoshitake J., Sawa T., Tomida J., Kawamura Y., Akaike T.: Identification of and screening for human Helicobacter cinaedi infections and carriers via nested PCR. J. Clin. Microbiol., 2012; 50: 3893-3900
- Zhu Y., Xian X., Wang Z., Bi Y., Chen Q., Han X., Tang D., Chen R.: Research progress on the relationship between atherosclerosis and inflammation. Biomolecules, 2018; 8: 80
- Libby P., Ridker P.M., Hansson G.K.: Progress and challenges in translating the biology of atherosclerosis. Nature, 2011; 473: 317325
- Gibson M.S., Domingues N., Vieira O.V.: Lipid and non-lipid factors affecting macrophage dysfunction and inflammation in atherosclerosis. Front. Physiol., 2018; 9: 654
- Araoka H., Baba M., Kimura M., Abe M., Inagawa H., Yoneyama A.: Clinical characteristics of bacteremia caused by Helicobacter cinaedi and time required for blood cultures to become positive. J. Clin. Microbiol., 2014; 52: 1519-1522
- Nakao S., Hagiya H., Kimura K., Mitsui T., Oyama A., Hongyo K., Takahashi Y., Nakagami F., Tomono K., Rakugi H.: Helicobacter cinaedi-associated carotid arteritis. Acta Med. Okayama, 2018; 72: 189-192
- Kawamura Y., Tomida J., Morita Y., Fujii S., Okamoto T., Akaike T.: Clinical and bacteriological characteristics of Helicobacter cinaedi infection. J. Infect. Chemother., 2014; 20: 517-526
- Lewis G.D., Holmes C.B., Holmvang G., Butterton J.R.: Case records of the Massachusetss General Hospital. Case 8-2007. A 48-year-old man with chest pain followed by cardiac arrest. N. Engl. J. Med., 2007; 356: 1153-1162
- Khan S., Rahman H.N., Okamoto T., Matsunaga T., Fujiwara Y., Sawa T., Yoshitake J., Ono K., Ahmed K.A., Rahaman M.M., et al.: Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci. Rep., 2014; 4: 4680
- Unosawa S., Niino T.: An infected abdominal aortic aneurysm caused by Helicobacter cinaedi. Ann. Vasc. Dis., 2015; 8: 318-320
- Nishidai K., Iwasawa T., Tamura A., Lefor A.T.: Infected abdominal aortic aneurysm with Helicobacter cinaedi. Case Rep. Surg., 2016, 2016: 1396568
- D’Elios M.M., Vallese F., Capitani N., Benagiano M., Bernardini M.L., Rossi M., Rossi G.P., Ferrari M., Baldari C.T., Zanotti G., et al.: The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells. Sci. Rep., 2017; 7: 40515
- Libby P., Ridker P.M., Hansson G.K., Leducq Transatlantic Network on Atherothrombosis: Inflammation in atherosclerosis: From pathophysiology to practice. J. Am. Coll. Cardiol., 2009; 54: 21292138
- Tabas I.: Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol., 2010; 10: 36-46
DOI: https://doi.org/10.2478/ahem-2021-0003 | Journal eISSN: 1732-2693
Language: English
Page range: 529 - 536
Submitted on: Mar 18, 2020
Accepted on: Dec 8, 2020
Published on: Oct 21, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2021 Tevhide Ziver Sarp, Safa Gode, Suat Saribas, Sevgi Ergin, Gökhan Kasnak, Harika Oyku Dinc, Halit Tokman, Banu Tufan Kocak, Melike Keskin, Hrisi Bahar Tokman, Bekir Kocazeybek, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.